"multiple myeloma" trang 3 - tải miễn phí từ tailieuXANH
The impact of disease-related symptoms and palliative care concerns on healthrelated quality of life in multiple myeloma: A multi-centre study

The impact of disease-related symptoms and palliative care concerns on healthrelated quality of life in multiple myeloma: A multi-centre study
16    90    0
A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma

A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma
6    64    0
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
10    110    0
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment

Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment
11    51    0
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: Role of DNA damage response activation

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: Role of DNA damage response activation
14    51    0
HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma

HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma
10    89    0
Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma

Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma
11    61    0
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
8    54    0
Bortezomib and dexamethasone for multiple myeloma: Higher AST and LDH levels associated with a worse prognosis on overall survival

Bortezomib and dexamethasone for multiple myeloma: Higher AST and LDH levels associated with a worse prognosis on overall survival
10    76    0
Understanding what matters most to people with multiple myeloma: A qualitative study of views on quality of life

Understanding what matters most to people with multiple myeloma: A qualitative study of views on quality of life
14    89    0
Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: A qualitative study

Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: A qualitative study
10    62    0
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma

N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
20    75    0
A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors

A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors
10    59    0
Time-dependent endpoints as predictors of overall survival in multiple myeloma

Time-dependent endpoints as predictors of overall survival in multiple myeloma
12    56    0
Diallyl thiosulfinate enhanced the anticancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway

Diallyl thiosulfinate enhanced the anticancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway
10    33    1
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
13    38    1
Hospitalization at the end of life in patients with multiple myeloma

Hospitalization at the end of life in patients with multiple myeloma
6    42    1
Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: A case report

Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: A case report
10    43    1
The work of managing multiple myeloma and its implications for treatment-related decision making: A qualitative study of patient and caregiver experiences

The work of managing multiple myeloma and its implications for treatment-related decision making: A qualitative study of patient and caregiver experiences
11    163    2
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/ Immunomodulators plus dexamethasone/ prednisone for the treatment of multiple myeloma: An indirect-comparison Metaanalysis of randomised controlled trials

Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/ Immunomodulators plus dexamethasone/ prednisone for the treatment of multiple myeloma: An indirect-comparison Metaanalysis of randomised controlled trials
15    25    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.